ReviewCurrent neuropharmacology2023

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.

Suélyn Koerich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.